Q4 2025 IPO Pipeline: A Market Retrospective
Dissecting the quarter's most significant public offerings — from record filings to compressed valuations across key sectors.
The final quarter of 2025 delivered a paradox: record filings against a backdrop of compressed valuations. For institutional investors parsing the signal from the noise, Q4 offered both cautionary tales and compelling entry points.
Q4 2025 at a Glance
S-1 Filings
73
↑ +34% vs Q3
Capital Raised
$18.2B
↓ -12% vs Q3
Median P/Rev Multiple
8.2x
↓ Down from 11.4x
The Numbers
Seventy-three companies filed S-1 registrations in Q4 — a 34% increase over the prior quarter. Yet aggregate capital raised fell 12%, as issuers accepted tighter pricing to secure market access before year-end window closures.
The IPO market doesn't reward patience or impatience equally. It rewards precision.
Sector Breakdown
The technology sector continued to dominate new listings, accounting for 41% of all filings. Healthcare followed at 22%, with financial services rounding out the top three at 15%.
Q4 IPO Filings by Sector
Notable trends included:
- AI infrastructure companies commanding premium valuations despite revenue concentration risks
- Climate technology issuers facing extended roadshow periods as investors demanded clearer unit economics
- Fintech listings recovering from the 2024 drawdown, with more conservative pricing strategies
Valuation Compression
The median price-to-revenue multiple for Q4 IPOs landed at 8.2x — down from 11.4x in Q3. This compression reflected:
- Rising interest rate expectations heading into 2026
- Increased secondary market supply from SPAC unwind activity
- Investor rotation toward profitability over growth narratives
Valuation Multiples: Q3 vs Q4 2025
| Metric | Q3 2025 | Q4 2025 |
|---|---|---|
| Median P/Revenue | 11.4x | 8.2x |
| Median P/Earnings (profitable) | 32x | 26x |
| Day-1 Pop (median) | +18% | +11% |
| 90-Day Return (median) | +6% | -3% |
| Oversubscription Rate | 4.2x | 2.8x |
Pipeline Outlook: 2026
As we enter 2026, the pipeline remains robust. Over 120 companies have confidentially filed, with the largest concentration in enterprise software and healthcare diagnostics.
Confidential Filings by Sector (2026 Pipeline)
The key question isn't whether the market will accommodate new supply — it's whether issuers will accept the market's terms.
Q4 2025 IPO Pipeline Sentiment
Neutral1.6:1 positive-to-negative ratio reflecting mixed signals: record S-1 filings (+34%) signal confidence, but compressed valuations (8.2x vs 11.4x P/Rev) and negative 90-day returns indicate pricing discipline is paramount.
Sources
- SEC EDGAR S-1 Filings
- PitchBook
- Renaissance Capital
Frequently Asked Questions
This analysis represents the views of The IPO Club Research team and does not constitute investment advice.
Newsletter
Stay ahead of the market.
Get IPO analysis, market intelligence, and macro outlooks delivered directly to your inbox.
Contact Us
Get in touch.
Have a question or want to discuss a specific opportunity? Send us a message and one of our team members will respond within one business day.
Continue Reading
Q1 2026 IPO Surge: Technology Sector Leads Market Revival
Analysis of Q1 2026 IPO activity showing technology companies driving market recovery with strong investor demand
The AI Infrastructure IPO Wave: Specialized Chipmakers and Data Center Operators Lead 2026 Listings
Analysis of the surge in AI-focused infrastructure companies going public, covering chipmakers, data center REITs, and networking equipment providers
If You Could Only Pick One IPO Strategy: Which Investor Are You?
Three distinct IPO investor archetypes. One critical question: when markets tighten, which strategy sleeps better? A framework for navigating growth, infrastructure, and strategic allocation in a reopening IPO pipeline.